CAM
GRCL

Cormorant Asset Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Cormorant Asset Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-125,000
Closed -$1.93M – 126
2021
Q1 		$1.93M Buy
+125,000
New +$1.93M 0.04% 104